212 related articles for article (PubMed ID: 23613875)
1. Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease.
Kumar R; Chaterjee P; Sharma PK; Singh AK; Gupta A; Gill K; Tripathi M; Dey AB; Dey S
PLoS One; 2013; 8(4):e61560. PubMed ID: 23613875
[TBL] [Abstract][Full Text] [Related]
2. Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
Shekhar S; Kumar R; Rai N; Kumar V; Singh K; Upadhyay AD; Tripathi M; Dwivedi S; Dey AB; Dey S
PLoS One; 2016; 11(7):e0159099. PubMed ID: 27459603
[TBL] [Abstract][Full Text] [Related]
3. Blood Circulatory Level of Seven Sirtuins in Alzheimer's Disease: Potent Biomarker Based on Translational Research.
Pradhan R; Singh AK; Kumar P; Bajpai S; Pathak M; Chatterjee P; Dwivedi S; Dey AB; Dey S
Mol Neurobiol; 2022 Mar; 59(3):1440-1451. PubMed ID: 34993847
[TBL] [Abstract][Full Text] [Related]
4. Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.
Rai N; Kumar R; Desai GR; Venugopalan G; Shekhar S; Chatterjee P; Tripathi M; Upadhyay AD; Dwivedi S; Dey AB; Dey S
J Alzheimers Dis; 2016 Oct; 54(3):1147-1155. PubMed ID: 27567861
[TBL] [Abstract][Full Text] [Related]
5. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
6. What Are the Reliable Plasma Biomarkers for Mild Cognitive Impairment? A Clinical 4D Proteomics Study and Validation.
Hou Z; Sun A; Li Y; Song X; Liu S; Hu X; Luan Y; Guan H; He C; Sun Y; Chen J
Mediators Inflamm; 2024; 2024():7709277. PubMed ID: 38883967
[TBL] [Abstract][Full Text] [Related]
7. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
[TBL] [Abstract][Full Text] [Related]
9. Serum FOXO3A: A ray of hope for early diagnosis of Alzheimer's disease.
Pradhan R; Yadav SK; Prem NN; Bhagel V; Pathak M; Shekhar S; Gaikwad S; Dwivedi SN; Bal CS; Dey AB; Dey S
Mech Ageing Dev; 2020 Sep; 190():111290. PubMed ID: 32603667
[TBL] [Abstract][Full Text] [Related]
10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.
Oh J; Lee HJ; Song JH; Park SI; Kim H
Exp Gerontol; 2014 Dec; 60():87-91. PubMed ID: 25304332
[TBL] [Abstract][Full Text] [Related]
12. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
Gattaz WF; Talib LL; Schaeffer EL; Diniz BS; Forlenza OV
J Neural Transm (Vienna); 2014 Feb; 121(2):193-200. PubMed ID: 24036895
[TBL] [Abstract][Full Text] [Related]
13. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
14. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
[TBL] [Abstract][Full Text] [Related]
15. Comparison of β2-microglobulin serum level between Alzheimer's patients, cognitive healthy and mild cognitive impaired individuals.
Dominici R; Finazzi D; Polito L; Oldoni E; Bugari G; Montanelli A; Scarpini E; Galimberti D; Guaita A
Biomarkers; 2018 Sep; 23(6):603-608. PubMed ID: 29741401
[TBL] [Abstract][Full Text] [Related]
16. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
Zhao S; Zhao J; Zhang T; Guo C
Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
[TBL] [Abstract][Full Text] [Related]
17. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
[TBL] [Abstract][Full Text] [Related]
19. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
Kumar A; Singh S; Verma A; Mishra VN
Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
[TBL] [Abstract][Full Text] [Related]
20. Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease.
Chiu MJ; Yang SY; Horng HE; Yang CC; Chen TF; Chieh JJ; Chen HH; Chen TC; Ho CS; Chang SF; Liu HC; Hong CY; Yang HC
ACS Chem Neurosci; 2013 Dec; 4(12):1530-6. PubMed ID: 24090201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
